Sarah J. Tabrizi

Has grant

Country flagUnited Kingdom

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

TREAT-HD: targeting neurodegeneration in Huntington's disease

Open Date: 2019-02-01

Close Date: 2021-07-01

Grant: Close

Investigation of genetic variation in MSH3, a DNA repair protein that modifies the course of Huntington's disease

Open Date: 2018-09-23

Close Date: 2022-09-29

Grant: Close

Mechanism of the DNA damage response in Huntington’s disease pathogenesis and relevance for therapeutics

Open Date: 2018-03-31

Close Date:

Grant: Close

Mechanism of the DNA damage response in Huntington’s disease pathogenesis and relevance for therapeutics

Open Date: 2018-03-31

Close Date:

Grant: Close

EXPLORING THE ROLE AND THERAPEUTIC POTENTIAL OF RAB GTPASES IN HUNTINGTON'S DISEASE

Open Date: 2018-03-31

Close Date: 2021-03-30

Articles (13)

The gene for Huntington's disease (HD) was discovered in 1993, after an international collaborative initiative that led researchers to remote regions of South America. It was the most remarkable milestone, since George Huntington's initial description. Through the phenomenological discussions led by Jean‐Martin Charcot and Willian Osler, and finally Americo Negrette's reports, which served as the inspiration for the Venezuela Project led by Nancy Wexler, the journey toward discovering the Huntington's disease (HD) gene was marked by substantial efforts. This monumental achievement involved the analysis of more than 18,000 blood samples and gathered dozens of researchers in an integrated effort, enabling the mapping of the gene on chromosome 4 in 1983 and leading, a decade later, to the precise localization and identification of the HTT gene. The discovery of the HD mutation represented a pivotal moment in the field of genetics and neurology, significantly enhancing our understanding of the disease and creating opportunities for future treatments. The progress made and the knowledge gained during this journey catalyzed the development of many innovative molecular techniques that have advanced research in other medical conditions. In this article, the authors celebrate three decades of this memorable event, revisiting the historical aspects, providing insights into the techniques developed, and delving into the paths that ultimately led to the discovery of the HD gene. © 2024 International Parkinson and Movement Disorder Society.

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (11)

Edward Wild

University College London

UNITED KINGDOM
View details

Daniel O. Claassen

-

UNITED STATES
View details

Rachael Scahill

University College London

UNITED KINGDOM
View details

Douglas Langbehn

Professor

Iowa State University

UNITED STATES
View details

Peter Wijeratne

University College London

UNITED KINGDOM
View details

Nellie Georgiou-Karistianis

MONASH UNIVERSITY

AUSTRALIA
View details

Jonathan Schott

UCL Institute of Neurology, University College London

UNITED KINGDOM
View details

christos proukakis

Professor of Neurology and Neurogenetics

University College London

UNITED KINGDOM
View details

Cristina Sampaio

Chief Medical Officer

-

UNITED STATES
View details

Simon Mead

-

UNITED KINGDOM
View details

Joanna Kenny

University College London

UNITED KINGDOM
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.